Sequana Medical NV
SQNMF
$1.22
$0.000.00%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -91.60% | -60.27% | -37.23% | -12.75% | 13.34% |
| Total Depreciation and Amortization | 60.23% | 24.72% | -6.96% | 26.88% | 92.49% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 605.10% | 586.16% | 572.88% | 538.15% | 384.64% |
| Change in Net Operating Assets | 71.97% | 31.27% | -111.64% | -1,736.12% | -575.33% |
| Cash from Operations | 29.20% | 30.79% | 30.28% | 22.48% | 14.51% |
| Capital Expenditure | 89.94% | 88.23% | 86.61% | 25.17% | -128.09% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 55.65% | 55.65% | 55.65% | -1,560.00% | -209.52% |
| Cash from Investing | 89.40% | 87.73% | 86.15% | 23.73% | -139.74% |
| Total Debt Issued | 545.60% | 916.00% | -- | 40.92% | -70.04% |
| Total Debt Repaid | 35.00% | 47.19% | 54.91% | 35.40% | 6.68% |
| Issuance of Common Stock | -73.99% | -46.29% | -26.10% | -26.60% | -27.09% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 76.95% | 79.95% | 82.54% | 38.46% | -26.22% |
| Cash from Financing | 65.45% | 59.62% | 60.33% | -6.43% | -45.37% |
| Foreign Exchange rate Adjustments | -104.07% | -81.13% | -48.61% | 428.17% | 353.36% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 124.65% | 114.62% | 107.50% | 48.72% | -103.69% |